11/14
08:22 am
akba
Vadadustat Alternative Dosing Study Results Published in the American Journal of Kidney Disease [Yahoo! Finance]
Low
Report
Vadadustat Alternative Dosing Study Results Published in the American Journal of Kidney Disease [Yahoo! Finance]
11/14
08:00 am
akba
Vadadustat Alternative Dosing Study Results Published in the American Journal of Kidney Disease
Medium
Report
Vadadustat Alternative Dosing Study Results Published in the American Journal of Kidney Disease
11/12
08:00 am
akba
Akebia Therapeutics to Present at the Jefferies London Healthcare Conference
Low
Report
Akebia Therapeutics to Present at the Jefferies London Healthcare Conference
11/11
11:14 pm
akba
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Low
Report
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
11/11
11:14 pm
akba
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Low
Report
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
11/9
08:53 am
akba
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Released Earnings Last Week And Analysts Lifted Their Price Target To US$5.50 [Yahoo! Finance]
Medium
Report
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Released Earnings Last Week And Analysts Lifted Their Price Target To US$5.50 [Yahoo! Finance]
11/8
02:21 am
akba
Akebia Therapeutics Inc (AKBA) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges ... [Yahoo! Finance]
Medium
Report
Akebia Therapeutics Inc (AKBA) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges ... [Yahoo! Finance]
11/7
07:00 am
akba
Akebia Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Low
Report
Akebia Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
11/7/2024
07:00 am
akba
akebia therapeutics, inc.
MISS
Report
1.4%
akebia therapeutics, inc.
8/8/2024
07:00 am
akba
akebia therapeutics, inc.
BEAT
Report
6.2%
akebia therapeutics, inc.
5/9/2024
07:00 am
akba
akebia therapeutics, inc.
IN-LINE
Report
3.1%
akebia therapeutics, inc.
3/14/2024
04:15 pm
akba
akebia therapeutics, inc.
BEAT
Report
24.1%
akebia therapeutics, inc.
11/8
02:18 pm
akba
Form SC 13G Akebia Therapeutics, Filed by: BlackRock, Inc.
Low
Report
Form SC 13G Akebia Therapeutics, Filed by: BlackRock, Inc.
11/7
07:17 am
akba
Form 10-Q Akebia Therapeutics, For: Sep 30
Low
Report
Form 10-Q Akebia Therapeutics, For: Sep 30
11/7
07:06 am
akba
Form 8-K Akebia Therapeutics, For: Nov 07
Low
Report
Form 8-K Akebia Therapeutics, For: Nov 07
10/22
06:07 pm
akba
Form SC 13G Akebia Therapeutics, Filed by: BlackRock, Inc.
Low
Report
Form SC 13G Akebia Therapeutics, Filed by: BlackRock, Inc.
10/22
08:06 am
akba
Form 8-K Akebia Therapeutics, For: Oct 22
High
Report
Form 8-K Akebia Therapeutics, For: Oct 22
10/16
07:36 am
akba
Form 8-K Akebia Therapeutics, For: Oct 15
Low
Report
Form 8-K Akebia Therapeutics, For: Oct 15
9/13
06:03 am
akba
Form EFFECT Akebia Therapeutics,
Low
Report
Form EFFECT Akebia Therapeutics,
9/3
04:08 pm
akba
Form S-3 Akebia Therapeutics,
Low
Report
Form S-3 Akebia Therapeutics,
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register